Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Support Care Cancer. 2021 Sep 29;30(2):1749–1757. doi: 10.1007/s00520-021-06597-9

Table 3.

Symptom questionnaire among those with paired data (at both SV and follow-up)

Symptom Frequency of moderate
or severe symptom
at SV (n = 40)
Frequency of moderate
or severe symptom at
follow-up (n = 40)
Insomnia 31% 33%
Weight change 36% 33%
Myalgias 28% 28%
Paresthesias 25% 28%
Hot flashes 18% 23%
Weakness 10% 21%
Fatigue 28% 21%
Pain 21% 18%
Sexuality 17% 15%
Memory 13% 13%
Menstrual changes 7% 13%
Vaginal dryness 21% 13%
Difficulty at work 10% 11%
Difficulty with relationships 11% 8%
Fertility 3% 3%
% weight change, median (IQR) 1.8% (−3.6%, 6.0%) n/a
Significant weight gain (> 10%) 15% n/a

Patients used a 4-item Likert scale ranging from none to severe to rate their concerns. For analysis, scores of none and mild, as well as moderate and severe, were grouped together